相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel antigens in type 1 diabetes: The importance of ZnT8
Janet M. Wenzlau et al.
CURRENT DIABETES REPORTS (2009)
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
P. Achenbach et al.
DIABETOLOGIA (2009)
Localization of insulinoma associated protein 2, IA-2 in mouse neuroendocrine tissues using two novel monoclonal antibodies
Natsumi Takeyama et al.
LIFE SCIENCES (2009)
Functional β-Cell Mass and Insulin Sensitivity Is Decreased in Insulin-Independent Pancreas-Kidney Recipients
Pieter Gillard et al.
TRANSPLANTATION (2009)
Identification of a Major Humoral Epitope in S1c30A8 (ZnT8)
Janet M. Wenzau et al.
IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE (2008)
S1C30A8 Is a Major Target of Humoral Autoimmunity in Type 1 Diabetes and a Predictive Marker in Prediabetes
Janet M. Wenzlau et al.
IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE (2008)
A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes
Janet M. Wenzlau et al.
DIABETES (2008)
Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic α-cells
Armen V. Gyulkhandanyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
GAD treatment and insulin secretion in recent-onset type 1 diabetes
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
Shilpa Oak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Janet M. Wenzlau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
Richard A. Jensen et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2007)
A genome-wide association study identifies novel risk loci for type 2 diabetes
Robert Sladek et al.
NATURE (2007)
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects - A 16-month, randomized, comparative trial
JS Skyler et al.
DIABETES CARE (2005)
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes
CD Agardh et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
Identification and cloning of a β-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules
F Chimienti et al.
DIABETES (2004)
In silico identification and expression of SLC30 family genes:: An expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression -: art. no. 32
M Seve et al.
BMC GENOMICS (2004)
Diabetes antibody standardization program: First assay proficiency evaluation
PJ Bingley et al.
DIABETES (2003)
A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes
H Borg et al.
DIABETES (2002)
Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes
J Graham et al.
DIABETES (2002)
Perpetuation of immunological memory: a relay hypothesis
R Nayak et al.
IMMUNOLOGY (2001)
The World Health Organization International Collaborative Study for Islet Cell Antibodies
AR Mire-Sluis et al.
DIABETOLOGIA (2000)
High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age
K Decochez et al.
DIABETES CARE (2000)
分享论文
